pmvpharma.com (PMVP) - Cash Funds per Single Share

Corporate emblem and logo of PMV Pharmaceuticals, Inc (PMVP)

A narrow specialization in a single mutation and challenges with securing insurance reimbursement create financial threats for PMV Pharmaceuticals (PMVP). The cash runway per share chart serves as a resilience indicator, where the value of 1.36 reflects this status. These risks are mitigated by high scientific prestige in p53 protein therapy and the diversification of molecule synthesis through external CDMO partners in New Jersey.

pmvpharma.com (PMVP) - Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for PMV Pharmaceuticals, Inc (PMVP)

- market price and analyst price targets:
- cash position and cash flow details:
Comprehensive company analysis:PMV Pharma - PMVP
Flagship merchandise of PMV Pharma

A conservative approach requires assessing the issuer's solvency through the lens of available capital. This indicator is calculated by dividing the total volume of liquid assets by the number of shares outstanding. By analyzing the cash per share distribution, an investor determines the margin of safety for covering revenue shortfalls. This is critical for PMV Pharmaceuticals (PMVP), as high clinical trial costs create a significant financial burden. An increase in this metric signals the company's ability to fund R&D without emergency equity issuance.